GlassScriptPhysician profile
Soo Jin Rhee
NPI 1255584090
$790.23
in general payments reported to CMS, 2019-2025
14 companies · $91.83 in 2025
The $91.83 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $76.69 · 2021: $112 · 2022: $41.29 · 2023: $253 · 2024: $63.20 · 2025: $91.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $142.90 | 2023 | Varithena Administration Pack |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.25 | 2021 | |
| Abbvie INC. | $108.72 | 2023-2025 | |
| Cook Medical LLC | $82.90 | 2019 | |
| Endologix LLC | $68.64 | 2025 | Torus Stent Graft System, Endocross Device |
| W. L. Gore & Associates, INC. | $60.91 | 2020 | |
| Tactile Systems Technology INC | $43.52 | 2019-2022 | |
| Acell, INC. | $42.97 | 2019 | |
| Bioventus LLC | $31.33 | 2023 | Nexus |
| E.R. Squibb & Sons, L.L.C. | $23.77 | 2022 | |
| Smith+Nephew, INC. | $21.96 | 2023 | Pico 7 |
| Cagent Vascular INC | $20.00 | 2024 | Serrantor |
| Teleflex LLC | $15.78 | 2020 | |
| Melinta Therapeutics, LLC | $14.58 | 2023 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soo Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.